Cargando…
Considerations for the Development of Nasal Dosage Forms
The anatomy and physiology of the nasal cavity provide unique advantages for accessing targets for local, systemic, and potentially central nervous system drug delivery. This chapter discusses these advantages and the challenges that must be overcome to reach these targets. The chapter then comprehe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120012/ http://dx.doi.org/10.1007/978-1-4614-7978-9_5 |
_version_ | 1783514882320105472 |
---|---|
author | Ehrick, Jason D. Shah, Samir A. Shaw, Charles Kulkarni, Vitthal S. Coowanitwong, Intira De, Samiran Suman, Julie D. |
author_facet | Ehrick, Jason D. Shah, Samir A. Shaw, Charles Kulkarni, Vitthal S. Coowanitwong, Intira De, Samiran Suman, Julie D. |
author_sort | Ehrick, Jason D. |
collection | PubMed |
description | The anatomy and physiology of the nasal cavity provide unique advantages for accessing targets for local, systemic, and potentially central nervous system drug delivery. This chapter discusses these advantages and the challenges that must be overcome to reach these targets. The chapter then comprehensively reviews nasal dosage forms, analytical testing, and regulatory requirements in the context of existing nasal spray products. Since nasal sprays are moving towards being preservative-free, the chapter covers specialized methods of achieving a sterile product, namely, formulation strategies, manufacturing strategies, and the device landscape that support this upcoming platform. Finally, the chapter reviews various pathways for regulatory approval around the world, for brand and generic, with particular emphasis on the growing acceptance of in vitro data for locally acting nasal spray products. |
format | Online Article Text |
id | pubmed-7120012 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71200122020-04-06 Considerations for the Development of Nasal Dosage Forms Ehrick, Jason D. Shah, Samir A. Shaw, Charles Kulkarni, Vitthal S. Coowanitwong, Intira De, Samiran Suman, Julie D. Sterile Product Development Article The anatomy and physiology of the nasal cavity provide unique advantages for accessing targets for local, systemic, and potentially central nervous system drug delivery. This chapter discusses these advantages and the challenges that must be overcome to reach these targets. The chapter then comprehensively reviews nasal dosage forms, analytical testing, and regulatory requirements in the context of existing nasal spray products. Since nasal sprays are moving towards being preservative-free, the chapter covers specialized methods of achieving a sterile product, namely, formulation strategies, manufacturing strategies, and the device landscape that support this upcoming platform. Finally, the chapter reviews various pathways for regulatory approval around the world, for brand and generic, with particular emphasis on the growing acceptance of in vitro data for locally acting nasal spray products. 2013-06-22 /pmc/articles/PMC7120012/ http://dx.doi.org/10.1007/978-1-4614-7978-9_5 Text en © American Association of Pharmaceutical Scientists 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Ehrick, Jason D. Shah, Samir A. Shaw, Charles Kulkarni, Vitthal S. Coowanitwong, Intira De, Samiran Suman, Julie D. Considerations for the Development of Nasal Dosage Forms |
title | Considerations for the Development of Nasal Dosage Forms |
title_full | Considerations for the Development of Nasal Dosage Forms |
title_fullStr | Considerations for the Development of Nasal Dosage Forms |
title_full_unstemmed | Considerations for the Development of Nasal Dosage Forms |
title_short | Considerations for the Development of Nasal Dosage Forms |
title_sort | considerations for the development of nasal dosage forms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120012/ http://dx.doi.org/10.1007/978-1-4614-7978-9_5 |
work_keys_str_mv | AT ehrickjasond considerationsforthedevelopmentofnasaldosageforms AT shahsamira considerationsforthedevelopmentofnasaldosageforms AT shawcharles considerationsforthedevelopmentofnasaldosageforms AT kulkarnivitthals considerationsforthedevelopmentofnasaldosageforms AT coowanitwongintira considerationsforthedevelopmentofnasaldosageforms AT desamiran considerationsforthedevelopmentofnasaldosageforms AT sumanjulied considerationsforthedevelopmentofnasaldosageforms |